Precision Drilling Corpor... (PDS)
Bid | 38.21 |
Market Cap | 586.59M |
Revenue (ttm) | 1.87B |
Net Income (ttm) | 109.19M |
EPS (ttm) | 5.44 |
PE Ratio (ttm) | 7.9 |
Forward PE | 6.61 |
Analyst | Buy |
Ask | 46.89 |
Volume | 59,731 |
Avg. Volume (20D) | 141,608 |
Open | 42.86 |
Previous Close | 42.72 |
Day's Range | 42.66 - 43.02 |
52-Week Range | 36.20 - 79.07 |
Beta | 1.78 |
Analyst Forecast
According to 0 analyst ratings, the average rating for PDS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
2 weeks ago · proactiveinvestors.co.uk
EMV Capital portfolio company PDS Biotech advances cancer trialPDS Biotechnology Corporation (NASDAQ:PDSB), a US cancer immunotherapy firm backed by EMV Capital (AIM:EMVC), has begun site activations for its phase III trial of Versamune HPV in patients with head ...

1 month ago · seekingalpha.com
Precision Drilling Corporation (PDS) Q1 2025 Earnings Call TranscriptPrecision Drilling Corporation (NYSE:PDS ) Q1 2025 Earnings Conference Call April 24, 2025 1:00 PM ET Company Participants Lavonne Zdunich - Vice President of Investor Relations Carey Ford - Chief Fin...

3 months ago · proactiveinvestors.co.uk
EMV Capital portfolio company PDS Biotechnology raises $11mlnEMV Capital plc (AIM: EMVC) portfolio company PDS Biotechnology Corporation (Nasdaq: PDSB) has raised $11 million, through an equity funding. PDS, which is focussed on immunotherapies, sold around 7.3...